Lieferanten für CAS
656247-17-5
|
Daten | CAS |
656247-17-5 | Formula |
C31H33N5O4 |
|
|
15 Registerierte Lieferanten
Amadis Chemical Company Limited
P.R.China
Weitere Informationen finden Sie hier
H&Z Industry Co.,Ltd
P.R.China
Xingrui Industry Co., Limited
P.R.China
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
Capot Chemical Co., Ltd.
P.R.China
Weitere Informationen finden Sie hier
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C31H33N5O4 Molecular Weight: 539.62482
Molecular Formula: C31H33N5O4 Molecular Weight: 539.62482
Molecular Formula: C20H16ClNO5 Molecular Weight: 385.79774
Shandong Minglang Chemical Co., Ltd
P.R.China
Aea.ltd
P.R.China
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
Nantong Xindao Biotech Ltd
P.R.China
Lori Industry Co., Ltd
P.R.China
Finetech Industry Limited
P.R.China
Weitere Informationen finden Sie hier
BOC Sciences
USA
Description: Nintedanib-[13C,d3] is the labelled analogue of Nintedanib. Nintedanib is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β. It is used for the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC). - Molecular Weight:543.65
- Purity:≥95%
Molecular Formula: C30[13C]H30D3N5O4 Canonical SMILES: CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O InChI: InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3/i1+1D3 InChIKey: CPMDPSXJELVGJG-KQORAOOSSA-N Solubility: Soluble in DMSO Appearance: Pale Yellow to Yellow Solid Storage: Store at-20°C Synonyms: Nintedanib 13CD3; [13C,2H3]-BIBF 1120; [13C,2H3]-Intedanib; [13C,2H3]-Vargatef; methyl (Z)-3-(((4-(N-methyl-2-(4-(methyl-13C-d3)piperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate; Ofev-13C,d3 Weitere Informationen finden Sie hier
Description: Nintedanib is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM. It is used for the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC). - Molecular Weight:539.62
- Melting Point:>237°C (dec.)
- Purity:≥98%
Molecular Formula: C31H33N5O4 Canonical SMILES: CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O InChI: InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3 InChIKey: CPMDPSXJELVGJG-UHFFFAOYSA-N Solubility: Soluble to 9.66 mg/L in water. Appearance: Light Green to Light Yellow Solid Synonyms: Vargatef; BIBF-1120; BIBF 1120; BIBF1120; Intedanib Weitere Informationen finden Sie hier
AK Scientific, Inc.
USA
CM Fine Chemicals
Switzerland
Detaillierte Informationen über die Lieferanten von
Intedanib
|